- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: AZD9833 with palbociclib
Total 17536 results
-
PfizerCompletedHealthy, Hepatic InsufficiencyUnited States
-
AstraZenecaParexelCompleted
-
AstraZenecaCompletedSeptic Shock | Severe SepsisCzech Republic, France, Spain, Finland, Canada, Australia, Belgium
-
PfizerCompleted
-
AstraZenecaRecruitingGastric Cancer | Pancreatic Ductal Adenocarcinoma | Esophageal Adenocarcinoma | Gastro-esophageal Junction CancerKorea, Republic of, United States, Japan, Taiwan, China, United Kingdom, Netherlands
-
PfizerCompletedHealthyUnited States
-
PfizerCompleted
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHormone Receptor Positive Advanced Breast CancerChina
-
Institut für Klinische Krebsforschung IKF GmbH...Recruiting
-
PfizerCompleted
-
PfizerRecruiting
-
PfizerCompletedBreast Cancer | Breast Neoplasms | Breast Tumors | Breast Carcinoma | Cancer of BreastIndia
-
InventisBio Co., LtdCompleted
-
AstraZenecaCompletedHyperlipidaemiaDenmark, Netherlands, Spain, Czechia, United States, Slovakia, Hungary, Poland
-
University of NebraskaRecruitingClinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine TherapyBreast CancerUnited States
-
PfizerRecruitingBreast NeoplasmsAustria, Germany
-
Royal Marsden NHS Foundation TrustPfizer; Roche Pharma AG; Institute of Cancer Research, United KingdomUnknownBreast Cancer | Advanced Solid TumoursUnited Kingdom
-
Razelle Kurzrock, MDWithdrawnCancer, AdvancedUnited States
-
AstraZenecaRecruitingHepatic ImpairmentUnited States
-
University of Milano BicoccaCompleted
-
Brown UniversityTaiho Oncology, Inc.RecruitingSoft Tissue Sarcoma | Advanced Breast Cancer | SCLC | Bladder Cancer | Endometrial Cancer | Treatment-Refractory Solid Tumors | Retinoblastoma DeficiencyUnited States
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdTerminatedHER2-positive Metastatic Breast CancerChina
-
PfizerCompleted
-
PfizerCompleted
-
Fundacion OncosurPfizer; Apices Soluciones S.L.; Pierre Fabre Ibérica, S.A.CompletedTriple Negative Breast CancerSpain
-
Grupo Espanol de Tumores NeuroendocrinosCompleted
-
AstraZenecaCompleted
-
German Breast GroupPfizer; AGO Study Group; Breast International Group; NSABP Foundation IncCompletedBreast Cancer | Hormonreceptor Positive | Her2-normal | Postneoadjuvant Treatment With CDK 4/6 Inhibitor | CPS-EG ScoreUnited States, Australia, Austria, Canada, France, Germany, Ireland, Japan, Korea, Republic of, Spain, United Kingdom
-
Northwestern UniversityNational Cancer Institute (NCI)Not yet recruitingMetastatic Breast Cancer | Estrogen-receptor-positive Breast Cancer | HER2/Neu-Negative Breast Cancer | Advanced Breast CancervUnited States
-
AstraZenecaTerminatedBreast NeoplasmKorea, Republic of, Germany, Taiwan
-
NiKang Therapeutics, Inc.PfizerRecruitingNeoplasms | Kidney Cancer | Kidney Neoplasms | Carcinoma, Renal Cell | Urologic Neoplasms | Urogenital Neoplasms | Neoplasms by Site | Kidney Diseases | Urologic Diseases | Adenocarcinoma | Carcinoma | Neoplasms, Glandular and Epithelial | Clear Cell Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Recurrent... and other conditionsUnited States
-
Namik Kemal UniversityNot yet recruitingCan the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 InhibitorsTurkey
-
AstraZenecaCompletedHealthy Volunteers | Tolerability | SafetyUnited Kingdom
-
Maastricht University Medical CenterNetherlands Thrombosis FoundationCompletedDeep Vein ThrombosisNetherlands
-
University of Colorado, DenverPfizer; Criterium, Inc.; Cascadian Therapeutics Inc.CompletedBreast CancerUnited States
-
AstraZenecaCompletedSeptic Shock | Severe SepsisJapan
-
PfizerActive, not recruitingMetastatic Breast CancerUnited States
-
Washington University School of MedicinePfizerCompletedCarcinoma, Squamous Cell of Head and NeckUnited States
-
AstraZenecaActive, not recruitingAdvanced ER-Positive HER2-Negative Breast CancerUnited States, Italy, Spain, Belgium, Poland, Canada, Germany, Korea, Republic of, Russian Federation, France, Israel, Hungary, Portugal, United Kingdom, Georgia, Ukraine
-
PfizerActive, not recruiting
-
Calithera Biosciences, IncCompletedNSCLC | Solid Tumors | KRAS Gene Mutation | CRCUnited States
-
ETOP IBCSG Partners FoundationPfizerRecruitingBreast Cancer RecurrentSwitzerland, Italy, France, Spain, Hungary, Austria
-
National Cancer Institute (NCI)RecruitingAdvanced Clear Cell Renal Carcinoma (Ccrcc) | Papillary Renal Cell Carcinoma (Prcc)United States
-
Forward Pharmaceuticals Co., Ltd.RecruitingMetastatic Breast Cancer | Breast Cancer Stage I | Locally Advanced Breast Cancer | ER+ Breast CancerChina
-
PfizerCompletedSquamous Cell Carcinoma of the Head and Neck (SCCHN)United States, Spain, Korea, Republic of, Czechia, Taiwan, Serbia, Japan, Slovakia, Mexico, Romania, Hungary, Italy, Poland, Russian Federation, Ukraine
-
Eisai Inc.Active, not recruitingBreast Neoplasms | Receptors, Estrogen | Genes, Erbb-2United States, United Kingdom
-
PfizerCompletedMetastatic Breast CancerSpain, Belgium, Sweden, United Kingdom, Austria, Germany, Switzerland
-
PfizerCompletedBreast NeoplasmsQatar, United Arab Emirates, Saudi Arabia
-
University of Michigan Rogel Cancer CenterWithdrawn